Biotechnology
Exyte acquires Kinetics Group to enhance global leadership in high-tech facility solutions
* Kinetics is a globally leading provider of installation services and equipment * Company serves high-tech industries such as semiconductor, biopharma, and batteries * 2,500 employees at more than 20 locations worldwide * Exyte to enter technical facility management business * Exyte...
2024-04-16 17:00
14
Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024
BUENOS AIRES, Argentina, April 15, 2024 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. (referred to as "LongBio"), a leading biotech company dedicated to developing innovative protein treatments for nephrology, allergy, respiratory, hematology, ophthalmology, and other autoimmune and rare dise...
2024-04-16 02:00
741
Next Bio Invests in Hiperbaric High-Pressure Processing Technology to Ramp Up Cold Brew Coffee Production
* Leading South Korean Cold Brew Producer Installs Hiperbaric Industrial HPP System to Boost Capacity to 6,000 Tons Per Year. * HPP ensures the safety and shelf life of cold-brew coffee up to 90 days while maintaining its freshness and flavor. MIAMI, April 16, 2024 /PRNewswire/ -- Next Bio,...
2024-04-16 01:29
913
First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial
Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer's disease Enrolment in XanaCIDD phase 2a trial of cognitive impairment and depression has surpassed 90% SYDNE...
2024-04-15 20:30
836
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING
TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is presenting for t...
2024-04-15 15:30
765
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment
PISCATAWAY, N.J., April 15, 2024 /PRNewswire/ -- On April 15, GenScript Biotech Corporation ("GenScript"), a world's leading technology and service provider of life science R&D and manufacture, announced that it has joined The Science Based Targets initiative (SBTi) and submitted the Science Base...
2024-04-15 15:04
689
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO
SINGAPORE, April 15, 2024 /PRNewswire/ -- Respiree announced today that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @South San Francisco[1] from February 12, 2024. By expanding footprint within the US, Respiree aims to deepen its relationships ...
2024-04-15 14:15
774
The 2024 Asia Agri-Tech Expo & Forum Demonstrates Taiwan's Prowess on Smart Farming & Biotechnology, brings in Future and Revolution to Agriculture, Livestock and Aquaculture Industries
TAIPEI, April 15, 2024 /PRNewswire/ -- Taiwan is renowned for its engineering prowess, manufacturing most of the components used in smart farming, including IoT sensors, solar panels, drones, robotics, and agriculture technology system integrators bringing revolutionary advancements to the field....
2024-04-15 09:00
1179
Bloomage Demonstrates Global Quality Management Excellence through On-Site Audit by Japan's PMDA
TOKYO, April 15, 2024 /PRNewswire/ -- Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted byJapan's Pharmaceuticals and Medical Devices Agency (PMDA). As the official regulatory agency for pharmaceuticals inJapan, the PMDA holds significant resp...
2024-04-15 08:30
862
【2024 AACR Late Breaking Research】TransThera announces clinical data of tinengotinib to treat patients with advanced solid tumors harboring actionable FGFR1-3 alterations
NANJING, China and GAITHURSBURG, Md., April 12, 2024 /PRNewswire/ -- TransThera Sciences, a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, announced the poster presentation at the 2024 American Association for Cancer Research (AACR) to disc...
2024-04-12 21:00
1581
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer
SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company dedicated to developing novel medicines to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ofDr. John Lee, MD, PhD, as its Chief Medical Office...
2024-04-11 14:59
1310
J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study
SEOUL, South Korea, April 11, 2024 /PRNewswire/ -- J INTS BIO announced the results of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, at the 8th April poster session of the 2024 American Cancer Research Society (AACR) Annual Meeting held inSan Diego,...
2024-04-11 14:56
1002
CSafe unveils cutting-edge innovations to meet cold chain customer needs
The company will launch three new technologies at the upcoming LogiPharma 2024 event MONROE, Ohio, April 10, 2024 /PRNewswire/ -- CSafe, a leading active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, announces it is launching three new technol...
2024-04-10 22:50
1729
Development of exosome therapy to treat inflammatory bowel disease by VesiCURE Therapeutics
SUZHOU, China, April 10, 2024 /PRNewswire/ -- IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions likeChina. It is a chronic, nonspecific inflammatory gastrointestinal disorder with an unknown etiology, characterize...
2024-04-10 21:15
1094
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research
NEWARK, Del., April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, including the 2024 International Organoid Summit, the Alzheimer's Research UK Conferenc...
2024-04-10 21:00
1165
MGI Tech Presents Latest Storage Product Series at ISBER 2024
MELBOURNE, Australia, April 10, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today showcased its latest storage solutions catering to a variety of sample storage needs, including MGICLab-LT*, MGICLab-LN55K*, and M...
2024-04-10 17:18
1516
Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024
BEIJING and PARIS, April 10, 2024 /PRNewswire/ -- On March 15th, Biologics 2024 successfully concluded inLondon, with 650 pharmaceutical, biotechnology, and academic representatives and over 50 exhibitors engaging in high-level discussions on the latest innovations in biologics discovery and deve...
2024-04-10 14:19
859
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research
TOKYO, April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been launching a continuous stream of innovative organoid-related products. Displaying their advancements at key global forums including the 2024 International Organoid Summit, Alzheimer's Research UK Conference 2024, and ...
2024-04-10 14:05
1440
R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm
SHENZHEN, China, April 10, 2024 /PRNewswire/ -- Recently, Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its wholly-owned subsidiary, Shenzhen Kexing Pharmaceutical Co., Ltd., had completed the enrollment of first p...
2024-04-10 11:41
1733
Alphamab Oncology Presented the Dose-escalation Results from JSKN003 in Patients with Advanced/Metastatic Solid Tumors at AACR
* The dose-escalation results of JSKN003 was reported at this AACR conference. * JSKN003 exhibited a favorable tolerability, safety profile and encouraging preliminary antitumor activity in patients with HER2-expressing advanced/metastatic solid tumors. The ORR in patients with HER2+ BC was 100...
2024-04-10 08:40
1512
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 320 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 298 media titles]
2024-04-15 17:33
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 287 media titles]
2024-04-12 15:14
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 274 media titles]
2024-04-15 08:00
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 273 media titles]
2024-04-11 11:00
Most Read
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
2024-04-11 11:00
6274
XCMG Machinery Launches Premium G2 Crane Brand
2024-04-12 14:39
5310
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
2024-04-12 15:14
4406
Cognizant Teams with Shopify and Google Cloud To Transform Enterprise Retail
2024-04-09 12:01
3534
PENSKE AUTOMOTIVE GROUP TO EXPAND RETAIL AUTOMOTIVE PRESENCE INTO AUSTRALIA
2024-04-09 04:15
3292